The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.